• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans



Online friends

None of your friends are currently online


Search Articles




Welcome back, Guest


features


Pinned  MitoMouse support

Sep 30 2019 12:44 PM | ImmInst in LongeCity

LongeCity supports the new SENS MitoMouse fundraiser at Lifespan.io led by the MITOSENS team in collaboration with the Buck Institute.



Read story →    0 comments    -----

SelfTesting Programme

Aug 07 2019 04:58 PM | ImmInst in LongeCity

LongeCity has long been a hotbed of information exchange and discussion about various methods of slowing or reversing the process of aging. An great number of supplements have been tried, exercise routines employed, and eating patterns explored.
Is it any of it working? Precious few people maintain a regular schedule of objective testing for health and aging biomarkers. Even fewer make those results public. LongeCity aims to change this state of affairs.
In order to foster a ‘citizen scientist’ culture of objective self-monitoring and knowledge sharing LongeCity is supporting efforts to run tests (assays) in its BASE programme, for aging biomarkers and in "N=1 experiments":



Read story →    0 comments    -----

About

Apr 09 2019 10:16 PM | ImmInst in LongeCity

The LongeCity (Longecity.org/ImmInst.org) is an international, not-for-profit, membership-based organization  Our mission is "to conquer the blight of involuntary death". To advance this mission, we aim to foster: • an open public forum...

Read story →    2 comments    *****


Newsletter

Oct 08 2018 06:43 PM | ImmInst in LongeCity

The LongeCity newsletter is usually send out on the 8th/18th day of each month to Members and registered forum users. To subscribe or unsubscribe: Visit this link and check if the box for 'Send me any updates sent by the board administrator' is check...

Read story →    1 comments    *****


Aging Biomarker Testing Support Programme

Jun 08 2018 07:32 PM | ImmInst in LongeCity

Background LongeCity.org has long been a hotbed of information exchange and discussion about various methods of slowing or reversing the process of aging. An incredible number of supplements have been tried, exercise routines employed, and eating pa...

Read story →    0 comments    -----

Write for LongeCity

Apr 28 2018 05:20 PM | caliban in LongeCity

There are different ways of writing for LongeCity, in two basic categories:Content and Articles All contributions are subject to the general LongeCityUser agreement. In short: authors keep full copyright of the article, but grant afree perpetual and...

Read story →    0 comments    -----


Cryonics

Apr 25 2018 10:52 PM | benbest in Articles

The following is a quick overview on Cryonics. NB: The information below is periodically reviewed for accuracy, but LongeCity makes no representations or gives any warranties whatsoever that the following information is accurate and complete at an...

Read story →    0 comments    *****


LongeCity Connect

Apr 01 2018 04:56 PM | caliban in LongeCity

Database of Experts, Advocates and Volunteers   LongeCity has been 'the' forum for information exchange on life extension for over a decade. Over the years, many of the 'who is who' in the scene have visited the site, newcom...

Read story →    0 comments    *****


'₮hank You' points explained

Jan 07 2018 11:14 PM | ThankYou in LongeCity

All registered users can earn '₮hank You' ('₮') points: By getting positive 'reputation' votes, or by getting direct'donations' from other members (anyone can donate by clicking on their ₮ count underneath theiravatar/portrait). By...

Read story →    0 comments    *****

Nootropics in human trials (Intro)

Sep 09 2017 12:15 PM | lukas_93 in Articles

by Lukas

 

Due to further advances in the field of neuropharmacology new possibilities of cognitive self-enhancement emerge.
Some are marketed as ‘smart drugs’, cognitive enhancers or nootropics.

 

This article aims to provide a brief overview.



Read story →    0 comments    ****-